Gilead ruling ‘threatens life-saving research’, says St Judes

The US Court of Appeals for the Federal Circuit should revisit a ruling in favour of Gilead Sciences that invalidated a cancer drug patent because the decision jeopardises research, according to St Judes Children’s Research Hospital.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Gilead avoids $1.2bn patent clash at SCOTUS

10 January 2023 Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma.

Medtech

Fed Circ revives claims in St Jude’s catheter patent suit

12 April 2022 Abbot-owned St Jude Medical will have to defend claims that its catheters infringe a company’s revived patent.

Big Pharma

Antitrust HIV drugs case should be arbitrated, argue Gilead, BMS

16 February 2021 Gilead Sciences and Bristol-Myers Squibb have said that a suit alleging they were involved in a long-running scheme to block generic competition and keep HIV medication prices artificially high is “legally defective”.

More on this story

Americas

Gilead avoids $1.2bn patent clash at SCOTUS

10 January 2023 Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma.

Medtech

Fed Circ revives claims in St Jude’s catheter patent suit

12 April 2022 Abbot-owned St Jude Medical will have to defend claims that its catheters infringe a company’s revived patent.

Big Pharma

Antitrust HIV drugs case should be arbitrated, argue Gilead, BMS

More on this story

Americas

Gilead avoids $1.2bn patent clash at SCOTUS

10 January 2023 Subsidiary held that its arguments were same as those cited in the much-anticipated Amgen v Sanofi | Dispute concerns a cancer treatment used to treat B-cell lymphoma.

Medtech

Fed Circ revives claims in St Jude’s catheter patent suit

12 April 2022 Abbot-owned St Jude Medical will have to defend claims that its catheters infringe a company’s revived patent.

Big Pharma

Antitrust HIV drugs case should be arbitrated, argue Gilead, BMS